Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA384952
Max Phase: Preclinical
Molecular Formula: C57H100N16O13
Molecular Weight: 1217.53
Molecule Type: Small molecule
Associated Items:
ID: ALA384952
Max Phase: Preclinical
Molecular Formula: C57H100N16O13
Molecular Weight: 1217.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCNCC[C@@H]1NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)C)[C@@H](C)O)CCNC(=O)[C@H]([C@@H](C)O)NC1=O
Standard InChI: InChI=1S/C57H100N16O13/c1-8-62-28-22-41-53(82)72-46(34(6)74)56(85)63-29-23-42(68-49(78)40(21-27-61)69-57(86)47(35(7)75)73-52(81)37(18-24-58)64-45(76)17-13-12-14-32(2)3)51(80)65-39(20-26-60)50(79)71-44(31-36-15-10-9-11-16-36)55(84)70-43(30-33(4)5)54(83)66-38(19-25-59)48(77)67-41/h9-11,15-16,32-35,37-44,46-47,62,74-75H,8,12-14,17-31,58-61H2,1-7H3,(H,63,85)(H,64,76)(H,65,80)(H,66,83)(H,67,77)(H,68,78)(H,69,86)(H,70,84)(H,71,79)(H,72,82)(H,73,81)/t34-,35-,37+,38+,39+,40+,41+,42+,43+,44-,46+,47+/m1/s1
Standard InChI Key: HHWPOJOSVYHATI-LHCJDOGCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1217.53 | Molecular Weight (Monoisotopic): 1216.7656 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Weinstein J, Afonso A, Moss E, Miller GH.. (1998) Selective chemical modifications of polymyxin B., 8 (23): [PMID:9873740] [10.1016/s0960-894x(98)00612-x] |
Source(1):